Search results
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 6 days agoMock said Moderna used a new antigen in its updated Covid vaccine to help focus on newer strains....
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
CNN.com· 6 days agoCalling the outcome of the late-stage trial “breakthrough results,” Moderna’s Chief Medical Affairs...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 2 days agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says - WSVN 7News...
7 News Miami· 6 days agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 1 day agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via AOL· 2 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
Scripps News via AOL· 2 days agoThe FDA is reversing course on its COVID vaccine guidance: Rather than having a vaccine that targets...
Combined COVID-flu vaccine shows positive results in late-stage trial, Moderna says
WISH-TV Indianapolis· 6 days agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 1 day agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
COVID cases rising in L.A. County and California as new subvariants make mark
LA Times via Yahoo News· 4 days agoThe FDA’s Vaccines and Related Biological Products Advisory Committee last week voted unanimously to...